Cancer · 1968 · 42 citations · 21 references
MedicineOncologyRadiation OncologyChemotherapyMedical OncologyTreatment PlanningMalignant NeoplasmsPalliative ChemotherapyPalliative RadiotherapyRadiation TherapyRadiobiological ConsiderationsClinical RemissionHodgkin Lymphoma RadiotherapyHodgkin Lymphoma TherapyHodgkin Lymphoma TreatmentLymphoma ChemotherapyPalliative Chemotherapy AdministrationPalliative Therapy
Of more than 600 patients with Hodgkin's disease seen at University Clinic, Freiburg, 340 patients received their primary treatment in the Clinic from 1948 to 1966. The following results are reported: 5-year survival rate, 48 per cent; 10-year survival rate, 28.7 per cent; 15-year survival rate, 21.2 per cent. The remission rate after the first treatment was 81.5 per cent; after 5 years, 24.4 per cent; after 10 years, 20.9 per cent; after 15 years, 20.9 per cent. This group of 20.9 per cent can be considered cured. Therapy results depend on stage of disease, clinical form of disease (types A and B) and on method of therapy. Marked improvement can be achieved only through radiation with tissue-destroying doses. Chemotherapy is a palliative treatment. The possibility of eradicating the disease makes it necessary that a critical plan for treatment—with cure as its objective—be worked out in all cases.
21
Epidemiology of Hodgkin's Disease
Brian MacMahon · The Lancet · 1973 · 486 citations
Public Health, Infectious Diseases, Clinical Epidemiology +13
Report of the Committee on the Staging of Hodgkin's Disease
Saul A. Rosenberg · Cancer Research · 1966 · 327 citations
Evidence for a tumoricidal dose level in the radiotherapy of Hodgkin's disease.
Henry S. Kaplan · PubMed · 1966 · 219 citations
E. C. Easson, M. H. Russell · BMJ · 1963 · 191 citations · Full text
Prophylactic treatment of adjacent areas in Hodgkin's disease.